RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Glenmark Ondansetron 4mg Recall

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glen

Updated December 30, 2025

Glenmark's Ondansetron 4mg orally disintegrating tablets have defective blister packs that are not fully sealed, causing tablets to fall out. This could lead to improper dosing or loss of medication.

Is the Glenmark Pharmaceuticals Inc., USA recalled? Yes. This product was recalled by FDA on December 30, 2025. Details below.

What is recalled

Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 tablets (3 blister cards, 10 tablets each). NDC: 68462-157-13. Manufactured for Glenmark Pharmaceuticals Inc., USA (Mahwah, NJ 07430). Product of India.

Am I affected

You're affected if you have a prescription bottle of Ondansetron 4mg orally disintegrating tablets with NDC number 68462-157-13, particularly if you notice the blister packs are not fully sealed or tablets are loose or falling out.

What to do right now

Do not use this medication if you notice the blister packs are not fully sealed or tablets are loose. Contact your pharmacy or the manufacturer, Glenmark Pharmaceuticals, to report the issue and request a replacement or refund.

The hazard

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Brands affected

Glenmark Pharmaceuticals Inc., USA
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0246-2026
Classification
Class II
Recalled
December 30, 2025
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls